Literature DB >> 33677472

Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis.

Rashmi Kanagal-Shamanna1, Guillermo Montalban-Bravo2, Panagiotis Katsonis3, Koji Sasaki2, Caleb A Class4, Elias Jabbour2, David Sallman5, Anthony Michael Hunter5, Christopher Benton2, Kelly S Chien2, Rajyalakshmi Luthra6, Carlos E Bueso-Ramos6, Tapan Kadia2, Michael Andreeff2, Rami S Komrokji5, Najla H Al Ali5, Nicholas Short2, Naval Daver2, Mark J Routbort6, Joseph D Khoury6, Keyur Patel6, Irene Ganan-Gomez2, Yue Wei2, Gautam Borthakur2, Farhad Ravandi2, Kim-Anh Do2, Kelly A Soltysiak2, Olivier Lichtarge3, L Jeffrey Medeiros6, Hagop Kantarjian2, Guillermo Garcia-Manero2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33677472      PMCID： PMC7936977          DOI： 10.1038/s41408-021-00446-y

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN： 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  15 in total

1.  Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer.

Authors:  David M Neskey; Abdullah A Osman; Thomas J Ow; Panagiotis Katsonis; Thomas McDonald; Stephanie C Hicks; Teng-Kuei Hsu; Curtis R Pickering; Alexandra Ward; Ameeta Patel; John S Yordy; Heath D Skinner; Uma Giri; Daisuke Sano; Michael D Story; Beth M Beadle; Adel K El-Naggar; Merrill S Kies; William N William; Carlos Caulin; Mitchell Frederick; Marek Kimmel; Jeffrey N Myers; Olivier Lichtarge
Journal:  Cancer Res       Date:  2015-01-29       Impact factor: 12.701

2.  Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes.

Authors:  D A Sallman; R Komrokji; C Vaupel; T Cluzeau; S M Geyer; K L McGraw; N H Al Ali; J Lancet; M J McGinniss; S Nahas; A E Smith; A Kulasekararaj; G Mufti; A List; J Hall; E Padron
Journal:  Leukemia       Date:  2015-10-30       Impact factor: 11.528

3.  A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies.

Authors:  Steffen Boettcher; Peter G Miller; Rohan Sharma; Marie McConkey; Matthew Leventhal; Andrei V Krivtsov; Andrew O Giacomelli; Waihay Wong; Jesi Kim; Sherry Chao; Kari J Kurppa; Xiaoping Yang; Kirsten Milenkowic; Federica Piccioni; David E Root; Frank G Rücker; Yael Flamand; Donna Neuberg; R Coleman Lindsley; Pasi A Jänne; William C Hahn; Tyler Jacks; Hartmut Döhner; Scott A Armstrong; Benjamin L Ebert
Journal:  Science       Date:  2019-08-09       Impact factor: 47.728

4.  Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients.

Authors:  Abdullah A Osman; David M Neskey; Panagiotis Katsonis; Ameeta A Patel; Alexandra M Ward; Teng-Kuei Hsu; Stephanie C Hicks; Thomas O McDonald; Thomas J Ow; Marcus Ortega Alves; Curtis R Pickering; Heath D Skinner; Mei Zhao; Eric M Sturgis; Merrill S Kies; Adel El-Naggar; Federica Perrone; Lisa Licitra; Paolo Bossi; Marek Kimmel; Mitchell J Frederick; Olivier Lichtarge; Jeffrey N Myers
Journal:  Cancer Res       Date:  2015-02-17       Impact factor: 12.701

Review 5.  Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy.

Authors:  Xuetian Yue; Yuhan Zhao; Yang Xu; Min Zheng; Zhaohui Feng; Wenwei Hu
Journal:  J Mol Biol       Date:  2017-04-06       Impact factor: 5.469

6.  Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases.

Authors:  Yun Shin Chun; Guillaume Passot; Suguru Yamashita; Maliha Nusrat; Panagiotis Katsonis; Jonathan M Loree; Claudius Conrad; Ching-Wei D Tzeng; Lianchun Xiao; Thomas A Aloia; Cathy Eng; Scott E Kopetz; Olivier Lichtarge; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2019-05       Impact factor: 12.969

7.  Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes.

Authors:  Guillermo Montalban-Bravo; Rashmi Kanagal-Shamanna; Christopher B Benton; Caleb A Class; Kelly S Chien; Koji Sasaki; Kiran Naqvi; Yesid Alvarado; Tapan M Kadia; Farhad Ravandi; Naval Daver; Koichi Takahashi; Elias Jabbour; Gautham Borthakur; Naveen Pemmaraju; Marina Konopleva; Kelly A Soltysiak; Sherry R Pierce; Carlos E Bueso-Ramos; Keyur P Patel; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Blood Adv       Date:  2020-02-11

8.  Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis.

Authors:  Zhen Zhao; Chi-Chao Chen; Cory D Rillahan; Ronglai Shen; Thomas Kitzing; Megan E McNerney; Ernesto Diaz-Flores; Johannes Zuber; Kevin Shannon; Michelle M Le Beau; Mona S Spector; Scott C Kogan; Scott W Lowe
Journal:  Nat Genet       Date:  2015-03-30       Impact factor: 38.330

9.  APR-246 reactivates mutant p53 by targeting cysteines 124 and 277.

Authors:  Qiang Zhang; Vladimir J N Bykov; Klas G Wiman; Joanna Zawacka-Pankau
Journal:  Cell Death Dis       Date:  2018-05-01       Impact factor: 8.469

Review 10.  Putting p53 in Context.

Authors:  Edward R Kastenhuber; Scott W Lowe
Journal:  Cell       Date:  2017-09-07       Impact factor: 41.582
View more
  3 in total

1.  EPIMUTESTR: a nearest neighbor machine learning approach to predict cancer driver genes from the evolutionary action of coding variants.

Authors:  Saeid Parvandeh; Lawrence A Donehower; Katsonis Panagiotis; Teng-Kuei Hsu; Jennifer K Asmussen; Kwanghyuk Lee; Olivier Lichtarge
Journal:  Nucleic Acids Res       Date:  2022-07-08       Impact factor: 19.160

Review 2.  Genome interpretation using in silico predictors of variant impact.

Authors:  Panagiotis Katsonis; Kevin Wilhelm; Amanda Williams; Olivier Lichtarge
Journal:  Hum Genet       Date:  2022-04-30       Impact factor: 5.881

3.  High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance.

Authors:  Hui Yang; Guillermo Garcia-Manero; Koji Sasaki; Guillermo Montalban-Bravo; Zhenya Tang; Yue Wei; Tapan Kadia; Kelly Chien; Diana Rush; Ha Nguyen; Awdesh Kalia; Manjunath Nimmakayalu; Carlos Bueso-Ramos; Hagop Kantarjian; L Jeffrey Medeiros; Rajyalakshmi Luthra; Rashmi Kanagal-Shamanna
Journal:  Leukemia       Date:  2022-08-01       Impact factor: 12.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.